NVO has been in the news 339% more than usual
Feb 09, 2026, 3:31 PM
-23.54%
What does NVO do
It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: Novo Nordisk's shares rose about 8% after Hims & Hers said it would stop selling an unapproved compounded Wegovy (semaglutide) copy offered at $49 a month following FDA warnings and legal threats. Novo Nordisk has sued Hims & Hers, citing patents on its GLP‑1 drugs that run until 2032 and noting roughly 1.5 million users of compounded GLP‑1 products.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.